Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy

International Journal of Gynecological Cancer

Volumn 22, Issue 5, 2012, Pages 881-888

  Manchanda, Ranjit ^a   Silvanto, Anna ^a   Abdelraheim, Ahmed ^b,c   Burnell, Matthew ^a   Johnson, Michelle ^a   Saridogan, Ertan ^d   Rosenthal, Adam N ^a,b   Brunell, Carol ^d   Aslam, Naaila ^d   Vashisht, Arvind ^d   Pandis, George ^d   Jacobs, Ian ^a,e   Menon, Usha ^a   Benjamin, Elizabeth ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c MINIA UNIVERSITY HOSPITAL   (Egypt)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

BRCA; Diathermy; Electrosurgery; Fallopian tube; Fimbrial; Occult pathology; Risk reducing salpingo oophorectomy; Thermal injury; Tubal injury

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIATHERMY; FEMALE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INJURY SEVERITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; THERMAL INJURY; UTERINE TUBE DISEASE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DIATHERMY; FALLOPIAN TUBE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84863696968     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31824b4093     Document Type: Article

References (33)

1. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 1991;48:232-242. (Pubitemid 21891587)
2. Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet. 1995;57:1457-1462.
3. Peto J, Collins N, Barfoot R, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999;91:943-949. (Pubitemid 29272520)
4. Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet. 1997;60: 496-504. (Pubitemid 27097597)
5. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117-1130. (Pubitemid 36530000)
6. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25:1329-1333. (Pubitemid 46706879)
7. Chen S, Iversen ES, Friebel T, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006;24:863-871. (Pubitemid 46638837)
8. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302:643-646. (Pubitemid 37310920)
9. Marroni F, Aretini P, D'Andrea E, et al. Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations. Eur J Hum Genet. 2004;12: 899-906. (Pubitemid 39462123)
10. Rennert G, Dishon S, Rennert HS, et al. Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel. Eur J Cancer Prev. 2005;14: 357-361. (Pubitemid 41104944)
11. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101:80-87.
12. Lamb JD, Garcia RL, Goff BA, et al. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy. Am J Obstet Gynecol. 2006;194: 1702-1709. (Pubitemid 43766909)
13. Kauff ND, Barakat RR. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J Clin Oncol. 2007;25:2921-2927. (Pubitemid 47123156)
14. Manchanda R, Abdelraheim A, Johnson M, et al. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG: An Int J of Obstet Gynaecol. 2011;118:814-824.
15. Greene MH, Mai PL, Schwartz PE. Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol. 2011;204:19.e1-19.e6.
16. Powell CB, Kenley E, Chen LM, et al. Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy. J Clin Oncol. 2005;23:127-132. (Pubitemid 41702631)
17. Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30:230-236. (Pubitemid 43740193)
18. Crum CP. Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol. 2009;3: 165-170.
19. Crum CP, Drapkin R, Kindelberger D, et al. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res. 2007;5:35-44. (Pubitemid 350218778)
20. Kindelberger DW, Lee Y, Miron A, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol. 2007;31: 161-169. (Pubitemid 46175016)
21. Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008;9:1191-1197.
22. Kurman RJ, Shih IeM. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433-443.
23. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol. 2008;27:1-9. (Pubitemid 351627965)
24. Crum CP, Drapkin R, Miron A, et al. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol. 2007;19:3-9. (Pubitemid 46095865)
25. Lee Y, Miron A, Drapkin R, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211:26-35. (Pubitemid 46092026)
26. Manchanda R, Burnell M, Abdelraheim A, et al. Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis. BJOG: An Int J of Obstet Gynaecol. 2012. doi: 10.1111/j.1471-0528.2011.03257.x.
27. Modi VK, Monforte H, Geller KA, et al. Histologic assessment of thermal injury to tonsillectomy specimens: a comparison of electrocautery, coblation, harmonic scalpel, and tonsillotome. Laryngoscope. 2009;119:2248-2251.
28. Finch A, Beiner M, Lubinski J, et al. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. JAMA. 2006;296:185-192.
29. Klingler CH, Remzi M, Marberger M, et al. Haemostasis in laparoscopy. Eur Urol. 2006;50:948-956; discussion 56-57.
30. Sutton PA, Awad S, Perkins AC, et al. Comparison of lateral thermal spread using monopolar and bipolar diathermy, the Harmonic Scalpel and the LigaSure. Br J Surg. 2010;97: 428-433.
31. Harrell AG, Kercher KW, Heniford BT. Energy sources in laparoscopy. Semin Laparosc Surg. 2004;11: 201-209. (Pubitemid 39517541)
32. Perko Z, Pogorelic Z, Bilan K, et al. Lateral thermal damage to rat abdominal wall after harmonic scalpel application. Surg Endosc. 2006;20:322-324. (Pubitemid 43130271)
33. Manchanda R, Drapkin R, Jacobs I, et al. The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer. Gynecol Oncol. 2012;124:185-191.